These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 225269)

  • 1. Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.
    Gershon AA; Steinberg SP
    Infect Immun; 1979 Jul; 25(1):164-9. PubMed ID: 225269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes.
    Gershon AA; Steinberg S; Smith M
    Infect Immun; 1976 Jun; 13(6):1549-53. PubMed ID: 184040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.
    Gershon AA; Steinberg SP
    Infect Immun; 1979 Jul; 25(1):170-4. PubMed ID: 225270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of varicella zoster virus in vitro: effect of leukocytes and specific antibody.
    Gershon AA; Steinberg SP
    Infect Immun; 1981 Aug; 33(2):507-11. PubMed ID: 6268546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.
    Schmidt NJ; Dennis J; Lennette EH
    Infect Immun; 1977 Mar; 15(3):850-4. PubMed ID: 192677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteins.
    Ito M; Ihara T; Grose C; Starr S
    J Virol; 1985 Apr; 54(1):98-103. PubMed ID: 2983124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to varicella-zoster virus.
    Arvin AM
    J Infect Dis; 1992 Aug; 166 Suppl 1():S35-41. PubMed ID: 1320649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic evidence of reinfection with varicella-zoster virus.
    Arvin AM; Koropchak CM; Wittek AE
    J Infect Dis; 1983 Aug; 148(2):200-5. PubMed ID: 6310001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic relationships among several simian varicella-like viruses and varicella-zoster virus.
    Felsenfeld AD; Schmidt NJ
    Infect Immun; 1977 Mar; 15(3):807-12. PubMed ID: 192676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response after exposure to varicella zoster virus: characterization of virus-specific antibodies and their corresponding antigens.
    Zweerink HJ; Neff BJ
    Infect Immun; 1981 Jan; 31(1):436-44. PubMed ID: 6260665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of immunity to varicella-zoster virus by means of an intradermal skin test.
    LaRussa P; Steinberg SP; Seeman MD; Gershon AA
    J Infect Dis; 1985 Nov; 152(5):869-75. PubMed ID: 2995511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
    Takayama M
    Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus.
    Shiraki K; Yamanishi K; Takahashi M
    J Infect Dis; 1984 Apr; 149(4):501-4. PubMed ID: 6327833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
    Grose C
    Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
    Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunology of chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection.
    Goldblatt D
    J Infect; 1998 Jan; 36 Suppl 1():11-6. PubMed ID: 9514103
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody response determined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization.
    Ihara T; Kato T; Torigoe S; Oitani K; Isaji M; Ito M; Kamiya H; Sakura M
    Acta Paediatr Jpn; 1991 Feb; 33(1):43-9. PubMed ID: 1649540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.